Zoonotic Disease Treatment Market Size, Share, Growth Analysis, By Types(Rabies, tuberculosis, malaria, leishmaniasis), By Causative Agent(Bacteria, virus, nematode, rodents), By Drug Class(Anti-Fungal, Anti-Bacterial, Antibiotics, and Others), By Route of Administration(Oral, Topical and Others.), By End-Users(Hospitals, Specialty Clinics, Homecare and Others), By Distribution Channel(Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others), By Region - Industry Forecast 2024-2031

Zoonotic Disease Treatment market size was valued at USD 36.91 billion in 2022 and is poised to grow from USD 39.16 billion in 2023 to USD 62.89 billion by 2031, at a CAGR of 6.1% during the forecast period (2024-2031).

The centers for disease control and prevention estimates that tens of thousands of Americans will fall ill each year from diseases that are transmitted from animals to people. Moreover, increased urbanization and rapid population growth are projected to worsen zoonotic diseases in the years to come. The market is driven by poor sanitation rates in metropolitan areas, which is another factor. In addition, rising demand for animal proteins is probably going to result in higher consumption of animal fats, which is anticipated to fuel the market for treating zoonotic diseases. Furthermore, with millions of households owning one or more pets, pets give entertainment and companionship. Yet, the rise of the same is anticipated to be fueled by some animals carrying dangerous diseases that can be transmitted to people and cause illness. However, the lack of knowledge about this zoonotic disease in poor nations and the high cost of research and development could slow the expansion of the market for zoonotic disease treatments. Furthermore, in the upcoming years, the global market would benefit from the development of novel medications for certain animal healthcare requirements.

US Zoonotic Disease Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.